(NASDAQ: ASPI) Asp Isotopes's forecast annual revenue growth rate of 115.7% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 5.57%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.15%.
Asp Isotopes's revenue in 2026 is $23,849,000.On average, 5 Wall Street analysts forecast ASPI's revenue for 2026 to be $4,372,500,811, with the lowest ASPI revenue forecast at $3,960,167,022, and the highest ASPI revenue forecast at $4,759,150,297. On average, 5 Wall Street analysts forecast ASPI's revenue for 2027 to be $11,413,651,084, with the lowest ASPI revenue forecast at $10,853,758,456, and the highest ASPI revenue forecast at $11,869,673,369.
In 2028, ASPI is forecast to generate $33,052,172,906 in revenue, with the lowest revenue forecast at $27,205,216,828 and the highest revenue forecast at $38,900,388,020.